Non-atherosclerotic aortic arch pathologies (NA-AAPs) and anatomical variants are
characterized as rare cardiovascular diseases with a low incidence rate, below 1 case per …

Even though diagnosis and management pathways have been substantially improved over
the last years, autoimmune rheumatic diseases (AIRDs) such as rheumatoid arthritis (RA) …

Objectives We evaluated sensitivity to change and discriminative abilities of vascular US
scores in disease monitoring in the follow-up of a prospective cohort of new-onset cranial …

Abstract Objectives Color Doppler ultrasound (CDUS) of the temporal arteries (TA) is
becoming the first test to be performed for suspected giant cell arteritis (GCA). Our aim was …

Background Takayasu arteritis (TAK) is an autoimmune large vessel vasculitis that affects
the aorta and its major branches, eventually leading to the development of aortic aneurysm …

Abstract Background Giant Cell Arteritis (GCA) is the commonest form of systemic vasculitis
in people over the age of 50. Published research highlighted the lack of a disease-specific …

Giant cell arteritis (GCA) is a chronic vasculitis that primarily affects the elderly, and can
cause visual impairment, requiring prompt diagnosis and treatment. The global impact of the …

Introduction SARS-CoV-2 infection and COVID-19 vaccines might have increased the
incidence of giant-cell arteritis (GCA) and the risk of associated stroke in Spain. Methods …

Objectives To characterise factors associated with permanent vision loss (PVL) and potential
reasons for the therapeutic delay contributing to PVL in giant cell arteritis (GCA). Methods …

Introduction Glucocorticoids (GC) have been part of the standard treatment of anti-neutrophil
cytoplasm autoantibodies (ANCA)-associated vasculitides (AAV) for more than 60 years …